14 April 2016 - The EMA and the European network for Health Technology Assessment (EUnetHTA) published today a report on their joint work plan covering the period between November 2012 and December 2015.

The EMA-EUnetHTA collaboration aims to create synergies between regulatory evaluation and health technology assessment (HTA) along the lifecycle of a medicine. The overall goal is to improve efficiency and quality of processes for the benefit of public health in the European Union.

The report highlights the value of EMA and EUnetHTA collaboration that fosters an approach to the generation of data on medicines, pre- and post-authorisation, that reconciles regulatory and HTA requirements into one clinical development programme. This is expected to improve the usefulness of the regulatory evaluation and the information derived from it for subsequent HTA. This will also enhance sharing experience and knowledge along the life span of medicines.

For more details, go to: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/04/news_detail_002510.jsp&mid=WC0b01ac058004d5c1